Fundraising Fox

Estrigenix Therapeutics

Wauwatosa, US · Delaware corporation · 1 known investors

Estrigenix Therapeutics is a pharmaceutical company developing first-in-class therapeutics based on estrogen biology to treat and prevent hot flashes and dementia in post-menopausal women. It aims to license its lead compounds to pharmaceutical companies after phase 2 clinical trials, offering menopause symptom relief without the breast cancer and stroke risks of traditional hormone replacement therapy.

BiotechDigital HealthFemTechHealthtech

Founders & leadership

BD
Bill DonaldsonChief Executive Officer
VR
Victoria R. ZellmerChief Executive Officer
DS
Daniel SemVice President of Business Development
WD
William DonaldsonPresident & Senior Vice President of Chemistry
KF
Karyn FrickChief Scientific Officer
PS
Patricia SchellerExecutive Chair
VZ
Victoria ZellmerCEO

Investors · 1

TalentsreportedMequon

Reported raises · per SEC filings

Form D private placements

$1M disclosed across 1 round · 2026

▶$1MraisedJul 2026 · 1 investors · Pharmaceuticals
Rule 506(b)
Estrigenix Therapeutics Raises $2M to Advance Selective Estrogen Therapy | Femtech Insiderfemtechinsider.com · Jul 2026Estrigenix Therapeutics, Inc. - WEDCwedc.org · Jul 2026
Officers, directors & promoters on the filing
  • Daniel SemExecutive Officer, Director
  • William DonaldsonExecutive Officer, Director
  • Karyn FrickExecutive Officer
  • Patricia SchellerDirector
  • Victoria ZellmerExecutive Officer
Offering amount
$2M
Amount sold
$1M
Minimum investment
$150K
Proceeds to insiders
$250K
First sale
Jul 2026
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 2

by search overlap
Generate Biomedicines3 shared keywordsGenerate:Biomedicines develops protein-based therapeutics using artificial intelligence and machine learning in a field it calls Generative Biology, combining computational protein design with biological engineering. The company creates new drugs on demand across diverse biologic modalities for immunology, oncology, infectious disease, and vaccines.
IRIS MEDICINE3 shared keywordsIris Medicine is an early-stage biotech developing RNA therapies based on its small binding RNA (sbRNA) platform, which uses cooperative RNAi binding to selectively silence mutant genes carrying expanded pathologic repeat sequences while preserving healthy alleles. Its lead programs target repeat expansion disorders including Huntington's Disease, C9orf72 ALS, and the Spinocerebellar Ataxias.

Companies competing with Estrigenix Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.

Non-dilutive funding · 1 SBIR/STTR award

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase I2022$299.1K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

In the news

Funding Rounds Report - Weekly of July 28, 2026. 76 funding rounds in the United States, United Kingdom, India etc.parsers.substack.com · Jul 2026Estrigenix Therapeutics, Inc. - WEDCwedc.org · Jul 2026Estrigenix Therapeutics Raises $2M to Advance Selective Estrogen Therapy | Femtech Insiderfemtechinsider.com · Jul 2026Estrigenix Therapeutics Raises 2.0M USD in Seed Funding | Seedtableseedtable.com · Jul 2026

Frequently asked questions

What does Estrigenix Therapeutics do?
Estrigenix Therapeutics is a pharmaceutical company developing first-in-class therapeutics based on estrogen biology to treat and prevent hot flashes and dementia in post-menopausal women. It aims to license its lead compounds to pharmaceutical companies after phase 2 clinical trials, offering menopause symptom relief without the breast cancer and stroke risks of traditional hormone replacement therapy.
Who are Estrigenix Therapeutics's investors?
Estrigenix Therapeutics's investors include Talents.
How much funding has Estrigenix Therapeutics raised?
Estrigenix Therapeutics has disclosed $1M raised across 1 round.
Where is Estrigenix Therapeutics headquartered?
Estrigenix Therapeutics is headquartered in Wauwatosa, US.